Introduction

Oliver Uecke

Chapter 1 in How to Commercialise Research in Biotechnology?, 2012, pp 1-10 from Springer

Abstract: Abstract Biotechnology is considered one of the key technologies of the 21st century (European Commission 2007a). The society as a whole faces the impact of the biotechnology sector (Patzelt 2005). Biotechnology influences patients’ life by providing innovative drugs, which address previously unmet medical needs and increase life expectancy (e.g. the monoclonal antibody Herceptin for the treatment of breast cancer). This has positive impact on a nation’s welfare because people are healthier and can work longer, but also costs impact on the health care system, due to the increased prices of innovative drugs (Neyt et al. 2006). Biotechnology could also provide solutions for the wider society to challenges such as an increase of the global population, higher demand for natural resources (food, animal feed, clean water, energy) and for health services (OECD 2009a).

Keywords: Technology Transfer; Innovation Process; Innovation Management; Initial Public Offering; Radical Innovation (search for similar items in EconPapers)
Date: 2012
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-8349-4134-3_1

Ordering information: This item can be ordered from
http://www.springer.com/9783834941343

DOI: 10.1007/978-3-8349-4134-3_1

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().